Cargando…

Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011

BACKGROUND: The extent of breast cancer outcome disparity can be measured by comparing Surveillance, Epidemiology, and End Results (SEER) breast cancer‐specific survival (BCSS) by region and with institutional cohort (IC) rates. METHODS: Patients who were diagnosed with a first primary, de novo, sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Malmgren, Judith A., Calip, Gregory S., Atwood, Mary K., Mayer, Musa, Kaplan, Henry G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004046/
https://www.ncbi.nlm.nih.gov/pubmed/31639221
http://dx.doi.org/10.1002/cncr.32531
_version_ 1783494649505120256
author Malmgren, Judith A.
Calip, Gregory S.
Atwood, Mary K.
Mayer, Musa
Kaplan, Henry G.
author_facet Malmgren, Judith A.
Calip, Gregory S.
Atwood, Mary K.
Mayer, Musa
Kaplan, Henry G.
author_sort Malmgren, Judith A.
collection PubMed
description BACKGROUND: The extent of breast cancer outcome disparity can be measured by comparing Surveillance, Epidemiology, and End Results (SEER) breast cancer‐specific survival (BCSS) by region and with institutional cohort (IC) rates. METHODS: Patients who were diagnosed with a first primary, de novo, stage IV breast cancer at ages 25 to 84 years from 1990 to 2011 were studied. The change in 5‐year BCSS over time from 1990 to 2011 was compared using the SEER 9 registries (SEER 9) without the Seattle‐Puget Sound (S‐PS) region (n = 12,121), the S‐PS region alone (n = 1931), and the S‐PS region IC (n = 261). The IC BCSS endpoint was breast cancer death confirmed from chart and/or death certificate and cause‐specific survival for SEER registries. BCSS was estimated using the Kaplan‐Meier method. Hazard ratios (HzR) were calculated using Cox proportional‐hazards models. RESULTS: For SEER 9 without the S‐PS region, 5‐year BCSS improved 7% (from 19% to 26%) over time, it improved 14% for the S‐PS region (21% to 35%), and it improved 27% for the S‐PS IC (29% to 56%). In the IC Cox proportional‐hazards model, recent diagnosis year, chemotherapy, surgery, and age <70 years were associated with better survival. For SEER 9, additional significant factors were white race and positive hormone receptor status and S‐PS region was associated with better survival (HzR, 0.87; 95% CI, 0.84‐0.90). In an adjusted model, hazard of BC death decreased in the most recent time period (2005‐2011) by 28% in SEER 9 without S‐PS, 43% in the S‐PS region and 45% in the IC (HzR, 0.72 [95% CI, 0.67‐0.76], 0.57 [95% CI, 0.49‐0.66], and 0.55 [95% CI, 0.39‐0.78], respectively). CONCLUSIONS: Over 2 decades, the survival of patients with metastatic breast cancer improved nationally, but with regional survival disparity and differential improvement. To achieve equitable outcomes, access and treatment approaches will need to be identified and adopted.
format Online
Article
Text
id pubmed-7004046
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70040462020-02-11 Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011 Malmgren, Judith A. Calip, Gregory S. Atwood, Mary K. Mayer, Musa Kaplan, Henry G. Cancer Original Articles BACKGROUND: The extent of breast cancer outcome disparity can be measured by comparing Surveillance, Epidemiology, and End Results (SEER) breast cancer‐specific survival (BCSS) by region and with institutional cohort (IC) rates. METHODS: Patients who were diagnosed with a first primary, de novo, stage IV breast cancer at ages 25 to 84 years from 1990 to 2011 were studied. The change in 5‐year BCSS over time from 1990 to 2011 was compared using the SEER 9 registries (SEER 9) without the Seattle‐Puget Sound (S‐PS) region (n = 12,121), the S‐PS region alone (n = 1931), and the S‐PS region IC (n = 261). The IC BCSS endpoint was breast cancer death confirmed from chart and/or death certificate and cause‐specific survival for SEER registries. BCSS was estimated using the Kaplan‐Meier method. Hazard ratios (HzR) were calculated using Cox proportional‐hazards models. RESULTS: For SEER 9 without the S‐PS region, 5‐year BCSS improved 7% (from 19% to 26%) over time, it improved 14% for the S‐PS region (21% to 35%), and it improved 27% for the S‐PS IC (29% to 56%). In the IC Cox proportional‐hazards model, recent diagnosis year, chemotherapy, surgery, and age <70 years were associated with better survival. For SEER 9, additional significant factors were white race and positive hormone receptor status and S‐PS region was associated with better survival (HzR, 0.87; 95% CI, 0.84‐0.90). In an adjusted model, hazard of BC death decreased in the most recent time period (2005‐2011) by 28% in SEER 9 without S‐PS, 43% in the S‐PS region and 45% in the IC (HzR, 0.72 [95% CI, 0.67‐0.76], 0.57 [95% CI, 0.49‐0.66], and 0.55 [95% CI, 0.39‐0.78], respectively). CONCLUSIONS: Over 2 decades, the survival of patients with metastatic breast cancer improved nationally, but with regional survival disparity and differential improvement. To achieve equitable outcomes, access and treatment approaches will need to be identified and adopted. John Wiley and Sons Inc. 2019-10-22 2020-01-15 /pmc/articles/PMC7004046/ /pubmed/31639221 http://dx.doi.org/10.1002/cncr.32531 Text en © 2019 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Malmgren, Judith A.
Calip, Gregory S.
Atwood, Mary K.
Mayer, Musa
Kaplan, Henry G.
Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title_full Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title_fullStr Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title_full_unstemmed Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title_short Metastatic breast cancer survival improvement restricted by regional disparity: Surveillance, Epidemiology, and End Results and institutional analysis: 1990 to 2011
title_sort metastatic breast cancer survival improvement restricted by regional disparity: surveillance, epidemiology, and end results and institutional analysis: 1990 to 2011
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004046/
https://www.ncbi.nlm.nih.gov/pubmed/31639221
http://dx.doi.org/10.1002/cncr.32531
work_keys_str_mv AT malmgrenjuditha metastaticbreastcancersurvivalimprovementrestrictedbyregionaldisparitysurveillanceepidemiologyandendresultsandinstitutionalanalysis1990to2011
AT calipgregorys metastaticbreastcancersurvivalimprovementrestrictedbyregionaldisparitysurveillanceepidemiologyandendresultsandinstitutionalanalysis1990to2011
AT atwoodmaryk metastaticbreastcancersurvivalimprovementrestrictedbyregionaldisparitysurveillanceepidemiologyandendresultsandinstitutionalanalysis1990to2011
AT mayermusa metastaticbreastcancersurvivalimprovementrestrictedbyregionaldisparitysurveillanceepidemiologyandendresultsandinstitutionalanalysis1990to2011
AT kaplanhenryg metastaticbreastcancersurvivalimprovementrestrictedbyregionaldisparitysurveillanceepidemiologyandendresultsandinstitutionalanalysis1990to2011